A 35-year-old man with lepromatous leprosy on anti-leprosy therapy for 3 months presents with acute onset fever, painful nodules on the skin, and tender nodular lesions. Which is the most common type of lepra reaction in this clinical scenario?

Explanation

## Lepra Reactions: Classification and Epidemiology **Key Point:** Type 2 lepra reaction (erythema nodosum leprosum, ENL) is the most common lepra reaction overall, occurring in approximately 50% of lepromatous leprosy (LL) and borderline lepromatous leprosy (BL) patients. ### Clinical Features of Type 2 Lepra Reaction (ENL) | Feature | Details | |---------|----------| | **Timing** | Occurs during treatment (weeks to months) or after completion | | **Pathophysiology** | Immune complex-mediated (Type III hypersensitivity) | | **Skin manifestations** | Tender, painful nodules; erythematous papules; panniculitis | | **Systemic features** | Fever, malaise, lymphadenopathy | | **Associated findings** | Neuritis, iritis, orchitis, glomerulonephritis | | **Leprosy type** | LL and BL patients (high bacillary load) | **High-Yield:** ENL is an immune complex deposition disease triggered by antigen-antibody complexes, NOT a delayed hypersensitivity reaction. It occurs in patients with high bacillary loads (LL/BL) and is more common during active treatment when bacterial antigens are released. ### Type 1 vs Type 2 Lepra Reactions | Parameter | Type 1 (Reversal Reaction) | Type 2 (ENL) | |-----------|----------------------------|---------------| | **Hypersensitivity type** | Type IV (delayed) | Type III (immune complex) | | **Leprosy types affected** | BT, BL, BB, BL | LL, BL | | **Timing** | Before, during, or after treatment | During or after treatment | | **Skin lesions** | Inflammatory changes in existing lesions | New tender nodules, panniculitis | | **Systemic involvement** | Rare | Common (fever, neuritis, iritis) | | **Frequency** | ~10% of patients | ~50% of LL/BL patients | **Clinical Pearl:** The presence of fever and tender nodules in a leprosy patient on treatment strongly suggests ENL rather than Type 1 reaction, which typically presents with inflammation of existing lesions without systemic symptoms. **Mnemonic: "ENL = Exudate, Nodules, Lymph" — helps recall that Type 2 is a systemic inflammatory response with immune complex deposition.** ### Why Type 2 is Most Common 1. LL and BL patients comprise a significant proportion of leprosy cases in endemic areas 2. High bacillary load provides abundant antigen for immune complex formation 3. ENL can occur in up to 50% of LL patients during or after treatment 4. Type 1 reactions occur in only ~10% of all leprosy patients [cite:Textbook of Dermatology by Valia & Valia, Lepra Reactions Chapter]